TELA Bio, Inc. (TELA) Return on equity 2019–2025
TELA Bio, Inc. (TELA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-615.1%FY2025 · since FY2019: -72.4% → -615.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -615.1% | -482.1 pp |
| FY2024 | -133.0% | +114.2 pp |
| FY2023 | -247.1% | +62.5 pp |
| FY2022 | -309.7% | -144.1 pp |
| FY2021 | -165.6% | -106.8 pp |
| FY2020 | -58.7% | +13.7 pp |
| FY2019 | -72.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice